179 related articles for article (PubMed ID: 1428229)
1. Effect of DNA ploidy classification on prognosis in breast cancer.
Joensuu H; Alanen K; Falkmer UG; Klemi P; Nordling S; Remvikos Y; Toikkanen S
Int J Cancer; 1992 Nov; 52(5):701-6. PubMed ID: 1428229
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
3. DNA content flow cytometry as a prognostic factor for node-positive breast cancer. The role of multiparameter ploidy analysis and specimen sonication.
Witzig TE; Gonchoroff NJ; Therneau T; Gilbertson DT; Wold LE; Grant C; Grande J; Katzmann JA; Ahmann DL; Ingle JN
Cancer; 1991 Oct; 68(8):1781-8. PubMed ID: 1913523
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of DNA ploidy determined by high-resolution flow cytometry in breast carcinoma.
Bracko M; Us-Krasovec M; Cufer T; Lamovec J; Zidar A; Goehde W
Anal Quant Cytol Histol; 2001 Feb; 23(1):56-66. PubMed ID: 11233744
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
[TBL] [Abstract][Full Text] [Related]
6. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of DNA ploidy and S-phase estimate in primary breast cancer: a prospective study.
Dieterich B; Albe X; Vassilakos P; Wieser S; Friedrich R; Krauer F
Int J Cancer; 1995 Sep; 63(1):49-54. PubMed ID: 7558451
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.
Clark GM; Mathieu MC; Owens MA; Dressler LG; Eudey L; Tormey DC; Osborne CK; Gilchrist KW; Mansour EG; Abeloff MD
J Clin Oncol; 1992 Mar; 10(3):428-32. PubMed ID: 1740681
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy as a major prognostic factor in resectable ampulla of Vater cancers.
Shyr YM; Su CH; Wu LH; Li AF; Chiu JH; Lui WY
J Surg Oncol; 1993 Aug; 53(4):220-5. PubMed ID: 8101889
[TBL] [Abstract][Full Text] [Related]
10. DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.
Fisher B; Gunduz N; Costantino J; Fisher ER; Redmond C; Mamounas EP; Siderits R
Cancer; 1991 Oct; 68(7):1465-75. PubMed ID: 1893345
[TBL] [Abstract][Full Text] [Related]
11. Relationship between DNA ploidy and survival in patients with primary breast cancer.
Eskelinen MJ; Pajarinen P; Collan Y; Pesonen E; Alhava E; Kettunen K; Nordling S
Br J Surg; 1989 Aug; 76(8):830-4. PubMed ID: 2765840
[TBL] [Abstract][Full Text] [Related]
12. The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
Eskelinen M; Nordling S; Puittinen J; Pesonen E; Collan Y
Pathol Res Pract; 1989 Nov; 185(5):694-7. PubMed ID: 2626377
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy and survival in breast cancer patients.
Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J
Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068
[TBL] [Abstract][Full Text] [Related]
14. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.
Baldetorp B; Fernö M; Fallenius A; Fallenius-Vecchi G; Idvall I; Olsson H; Sigurdsson H; Akerman M; Killander D
Cytometry; 1992; 13(6):577-85. PubMed ID: 1451590
[TBL] [Abstract][Full Text] [Related]
15. DNA content and S-phase fraction in male breast carcinomas.
Hatschek T; Wingren S; Carstensen J; Hultborn R
Acta Oncol; 1994; 33(6):609-13. PubMed ID: 7946436
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients.
Beerman H; Kluin PM; Hermans J; van de Velde CJ; Cornelisse CJ
Int J Cancer; 1990 Jan; 45(1):34-9. PubMed ID: 2298504
[TBL] [Abstract][Full Text] [Related]
17. Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer.
Stanton PD; Cooke TG; Oakes SJ; Winstanley J; Holt S; George WD; Murray GD
Br J Cancer; 1992 Nov; 66(5):925-9. PubMed ID: 1419638
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of DNA ploidy in 653 Japanese women with node-negative breast cancer.
Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
Int J Clin Oncol; 2001 Aug; 6(4):177-82. PubMed ID: 11706555
[TBL] [Abstract][Full Text] [Related]
19. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
[TBL] [Abstract][Full Text] [Related]
20. Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy.
Brooks SA; Leathem AJ; Camplejohn RS; Gregory W
Breast Cancer Res Treat; 1993; 25(3):247-56. PubMed ID: 8369526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]